financetom
Business
financetom
/
Business
/
Linde Insider Sold Shares Worth $4,747,451, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Linde Insider Sold Shares Worth $4,747,451, According to a Recent SEC Filing
Mar 14, 2024 5:16 AM

07:52 AM EDT, 03/14/2024 (MT Newswires) -- Sean Durbin, Executive VP, North America, around March 11, 2024, sold 10,208 shares in Linde ( LIN ) for $4,747,451. Following the Form 4 filing with the SEC, Durbin has control over a total of 8,151 shares of the company, with 8,151 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1707925/000170792524000072/xslF345X03/wk-form4_1710379715.xml

Price: 476.6, Change: +1.71, Percent Change: +0.36

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Nikola Stock After Its Reverse Split?
What's Going On With Nikola Stock After Its Reverse Split?
Jun 25, 2024
Nikola Corporation ( NKLA ) shares are trading lower Tuesday after the stock began trading on a reverse split-adjusted basis.  The Details: Nikola ( NKLA ) effected a 1-for-30 reverse stock split after the closing bell Monday and shares commenced trading on a split-adjusted basis Tuesday morning. The company also filed a prospectus with the SEC regarding the offering of...
Market Chatter: Sanofi Seeks Initial Bids for Consumer Health Division
Market Chatter: Sanofi Seeks Initial Bids for Consumer Health Division
Jun 25, 2024
01:15 PM EDT, 06/25/2024 (MT Newswires) -- Sanofi ( SNY ) has called for initial bids for its $20 billion consumer health business, Bloomberg reported Tuesday, citing people familiar with the matter. The French drugmaker has asked potential bidders to make first-round offers by mid-July, the people reportedly told Bloomberg. Concurrently, the company is working to spin off the division...
Update: Alnylam Pharmaceuticals Shares Rise as Heart Disease Candidate Meets Primary Endpoint in Late-Stage Study
Update: Alnylam Pharmaceuticals Shares Rise as Heart Disease Candidate Meets Primary Endpoint in Late-Stage Study
Jun 25, 2024
01:17 PM EDT, 06/25/2024 (MT Newswires) -- (Updates to reflect stock price movement in the headline and first paragraph.) Alnylam Pharmaceuticals ( ALNY ) shares were up more than 6% in recent Tuesday trading, a day after the company said vutrisiran, an investigational therapy for treating ATTR amyloidosis with cardiomyopathy, met its primary and secondary endpoints in a late-stage study....
Connexa Sports to Implement 1-For-20 Reverse Stock Split
Connexa Sports to Implement 1-For-20 Reverse Stock Split
Jun 25, 2024
01:16 PM EDT, 06/25/2024 (MT Newswires) -- Connexa Sports Technologies ( YYAI ) said Tuesday it is implementing a one-for-20 reverse stock split to help regain compliance with the minimum bid price requirement for continued listing on Nasdaq. The company said its shares will begin trading on a split-adjusted basis when the market opens on June 27. The shares were...
Copyright 2023-2026 - www.financetom.com All Rights Reserved